Contracts & Grants

Information is courtesy of The Office of Sponsored Projects (OSP). Each listing includes the faculty member's name and school appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

Due to confidentiality concerns in Clinical Trial Agreements from some pharmaceutical companies, the OSP no longer publishes some pharmaceutical awards in Distinctions.

New

Catherine G. Ambrose, Medical School (MS), PLX Pharma Inc., $7,700, PC-NSAIDs Gastrointestinal-Safe and Potent Anti- Inflammatory Drugs

Valentin Dragoi, MS and Graduate School of Biomedical Sciences (GSBS), University of California at San Francisco, $240,000, Network Mechanisms of Visual Behavior

Miguel Escobar, MS, Emory University, $5,060, Risk Factors for Inhibitor Development in Mild or Moderate Hemophilia A

Yun-Xin Fu, School of Public Health (SPH) and GSBS, Marshfield Clinic Research Foundation, $21,685, Molecular Epidemiology of Community-Associated MRSA

Sandra K. Hanneman, School of Nursing (SON), Texas Nurses Association, $1,500, Biomarker Circadian Rhythm Profiles in Mechanically Ventilated, Critically Ill Patients

Orieji C. Illoh, MS, Gulf Coast Regional Blood Center, $28,000, The Effect of Poloxamer 188 (P188) on the Storage of Red Blood Cells

Ronald H. Kerman, MS, Angiolast Systems Inc., $90,351, Stem Cell Studies: MI Study

John W. Lindsey, MS and GSBS, EMD Serono Inc., $85,625, The Cellular Immune Response against Epstein-Barr Virus in Multiple Sclerosis

Michael Lorenz, MS and GSBS, University of Mississippi Medical Center, $34,748, Molecular Targets of Novel Antifungal Compounds

David W. Marshak, MS and GSBS, Society for Neuroscience, $2,000, Houston Area Chapter SFN BAW Support

Maureen D. Mayes, MS, Fred Hutchinson Cancer Research Center, $9,892, Pregnancy, Microchimerism and Autoimmune Disease; University of California at Los Angeles, $30,300, Provisional Combined Response Index for Patients with Diffuse Systemic Sclerosis

Richard A. Meisch, MS and GSBS, King's College London Institute of Psychiatry, $30,618, Comprehensive Database of Drug Discrimination and Self-Administration Research

Eduardo J. Sanchez, SPH, Paso Del Norte Health Foundation, $88,734, Review and Update of the Paso Del Norte Health Foundation Strategic Plan

Arnold J. Schecter, SPH, Gustavus and Louise Pfeiffer Research Foundation, $74,900, Chemical Contamination of the US Food Supply

George M. Stancel, GSBS and MS, University of Houston, $28,014, Salary Reimbursement Agreement - GSBS Student

Joan Wasserman, SON, Rehabilitation Nursing Foundation, $11,990, Measuring Health Related Quality of Life in Stroke Survivors and Spousal Caregivers

Xinping Zhao, MS and GSBS, National Institutes of Health, $403,525, A Potential Zebrafish Model of Glaucoma by Genetic Ablation and Modification of the Annular Ligament Cells

Lei Zheng, MS and GSBS, American Heart Association, National, $308,000, Structural and Functional Relationship of Intracellular Regulation Mechanism of Calcium/Sodium Exchangers

Renewal

Eric Boerwinkle, SPH and GSBS, University of Michigan, $4,275,889, Genomic Approaches to Common Chronic Disease

Carrie L. Dodrill, MS, Texas Department of State Health Services, $73,060, Screening Brief Intervention Referral and Treatment Project (SA/SBT)

Jacqueline T. Hecht, MS and GSBS, Shriners Hospital for Crippled Children, $250,000, Functional and Regulatory Studies of Cartilage Oligomeric Matrix Protein (COMP); Shriners Hospital for Crippled Children, $180,787, Candidate Gene Studies in Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)

James E. Hixson, SPH and GSBS, University of Alabama at Birmingham, $704,078, Genetic and Environmental Determinants of Triglycerides

Shih Ning Liaw, MS, Texas Department of State Health Services, $252,411, C.H.O.S.E.N. Program

Maria T. Morandi, SPH, Mickey Leland National Urban Air Toxics Research Center, $1,100,000, Houston Exposure to Air Toxics Study (HEATS) - Phase 1

Stephen B. Tucker, MS, Clayton Foundation for Research, $38,850, The Anti-Tumor Effects of Interferon on Squamous Cell Carcinoma

Jerry S. Wolinsky, MS and GSBS, Clayton Foundation for Research, $91,666,Viral Mimicry and Multiple Sclerosis

Previous story Next story